CVC Strategic Opportunities II exits Genetic Group
CVC Strategic Opportunities II has agreed to sell its entire stake in Genetic SpA, a pharmaceutical contract development and manufacturing organisation that focuses on the dossier development and supply of products for the Respiratory, Ophthalmic and Oncology therapeutic areas.
